A new era for motif resources
The team behind JASPAR, led by Anthony Mathelier at NCMBM, has released the 11th update. JASPAR is built and maintained by an international consortium of research groups, making it a global effort to support the genomics research landscape for studying how genes are regulated.
Inborn errors of immunity (IEIs) are a diverse group of more than 550 rare genetic disorders that disrupt how the immune system develops and functions. For patients, this can mean vulnerability to severe infections, autoimmunity, inflammatory diseases, or even cancer. Current treatment options are limited and often carry significant risks, leaving many families in search of safer and more precise therapies.
Researchers uncover how loss of a gene called MAP4K1 amplifies T cell responses, offering insights into immune disorders and potential therapies.
On the 3rd to 4th of June, NCMBM and Associate Investigators gathered at the Sundvolden Hotel near Oslo, for two days of scientific talks, networking, and community building.
The Better Therapies for Rare Immune Diseases group, led by Emma Haapaniemi, has been extended for a further 4 years, following its successful evaluation by NCMBM’s Scientific Advisory Board (SAB).
